{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:03:21Z","timestamp":1788437001405,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jchromb.2024.124424","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:09:27Z","timestamp":1733616567000},"page":"124424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantification of gimeracil, tegafur, and 5-FU in human plasma via LC-MS\/MS with a simplified pretreatment using flow-through extraction"],"prefix":"10.1016","volume":"1251","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-0588","authenticated-orcid":false,"given":"Motozumi","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Seike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Gocho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124424_b0005","first-page":"413","article-title":"5-fluorouracil therapeutic drug monitoring and adverse events in a Romanian population","volume":"96","author":"Deac","year":"2023","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.jchromb.2024.124424_b0010","doi-asserted-by":"crossref","first-page":"e929474","DOI":"10.12659\/MSM.929474","article-title":"Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy","volume":"27","author":"Zhou","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jchromb.2024.124424_b0015","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1038\/s41598-021-82908-8","article-title":"Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS\/MS and clinical application in monitoring UFT\/LV combination therapy after hepatectomy","volume":"11","author":"Shiraiwa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2024.124424_b0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FTD.0000000000000768","article-title":"Phenotyping of Uracil and 5-Fluorouracil Metabolism Using LC-MS\/MS for Prevention of Toxicity and Dose Adjustment of Fluoropyrimidines","volume":"42","author":"Tafzi","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124424_b0025","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/rcm.8531","article-title":"High-throughput method to analyze tegafur and 5-fluorouracil in human tears and plasma using hydrophilic interaction liquid chromatography\/tandem mass spectrometry","volume":"33","author":"Shiokawa","year":"2019","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2024.124424_b0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jpba.2016.07.027","article-title":"LC-MS\/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma","volume":"129","author":"Holleran","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124424_b0035","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/bmc.3743","volume":"30","author":"Ishii","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124424_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jchromb.2012.04.010","article-title":"Development and utilization of a combined LC-UV and LC-MS\/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT\u00ae\/leucovorin","volume":"898","author":"Peer","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124424_b0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.2741","article-title":"LC-MS\/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients","volume":"27","author":"B\u00fcchel","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124424_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/rcm.3362","article-title":"Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"22","author":"Kosovec","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2024.124424_b0055","first-page":"152","article-title":"Severe adverse effects of 5-fluorouracil in S-1 were lessened by haemodialysis due to elimination of the drug","volume":"2","author":"Inoue","year":"2009","journal-title":"NDT Plus"},{"key":"10.1016\/j.jchromb.2024.124424_b0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpba.2010.01.026","article-title":"Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry","volume":"52","author":"Liu","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124424_b0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2116\/analsci.25.1211","article-title":"Simultaneous determination of tegafur and gimeracil in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"25","author":"Gu","year":"2009","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jchromb.2024.124424_b0070","unstructured":"Guideline on Bioanalytical Method Validation in Pharmaceutical Development, (2013) 1\u201320. http:\/\/www.nihs.go.jp\/drug\/BMV\/250913_BMV-GL_E.pdf (accessed February 8, 2024)."},{"key":"10.1016\/j.jchromb.2024.124424_b0075","unstructured":"R Core Team, R: A Language and Environment for Statistical Computing, (2018). https:\/\/www.r-project.org\/."},{"key":"10.1016\/j.jchromb.2024.124424_b0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/aps.2012.169","article-title":"Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients","volume":"34","author":"Zhuang","year":"2013","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:57:09Z","timestamp":1736434629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224004331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"alternative-id":["S1570023224004331"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124424","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of gimeracil, tegafur, and 5-FU in human plasma via LC-MS\/MS with a simplified pretreatment using flow-through extraction","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124424"}}